CONTEXT: The insulinoma syndrome is marked by fasting hypoglycemia and inappropriate elevations of insulin. The gastrinoma syndrome is characterized by hypergastrinemia, ulcer disease, and/or diarrhea. Rarely, insulinoma and gastrinoma coexist in the same patient simultaneously. OBJECTIVE: Our objective was to determine the cause of a patient's hypoglycemic episodes and peptic ulcer disease. DESIGN AND SETTING: This is a clinical case report from the Clinical Research Center of the National Institutes of Health. PATIENT AND INTERVENTION: One patient with hypoglycemic episodes and peptic ulcer disease had a surgical resection of neuroendocrine tumor. RESULTS: The patient was found to have a single tumor cosecreting both insulin and gastrin. Resection of this single tumor was curative. CONCLUSIONS: A single pancreatic neuroendocrine tumor may lead to the expression of both the hyperinsulinemic and hypergastrinemic syndromes.
CONTEXT: The insulinoma syndrome is marked by fasting hypoglycemia and inappropriate elevations of insulin. The gastrinoma syndrome is characterized by hypergastrinemia, ulcer disease, and/or diarrhea. Rarely, insulinoma and gastrinoma coexist in the same patient simultaneously. OBJECTIVE: Our objective was to determine the cause of a patient's hypoglycemic episodes and peptic ulcer disease. DESIGN AND SETTING: This is a clinical case report from the Clinical Research Center of the National Institutes of Health. PATIENT AND INTERVENTION: One patient with hypoglycemic episodes and peptic ulcer disease had a surgical resection of neuroendocrine tumor. RESULTS: The patient was found to have a single tumor cosecreting both insulin and gastrin. Resection of this single tumor was curative. CONCLUSIONS: A single pancreatic neuroendocrine tumor may lead to the expression of both the hyperinsulinemic and hypergastrinemic syndromes.
Authors: L I Larsson; L Grimelius; R Håkanson; J F Rehfeld; F Stadil; J Holst; L Angervall; F Sundler Journal: Am J Pathol Date: 1975-05 Impact factor: 4.307
Authors: B Hirshberg; A Livi; D L Bartlett; S K Libutti; H R Alexander; J L Doppman; M C Skarulis; P Gorden Journal: J Clin Endocrinol Metab Date: 2000-09 Impact factor: 5.958
Authors: Marc J Berna; K Martin Hoffmann; Jose Serrano; Fathia Gibril; Robert T Jensen Journal: Medicine (Baltimore) Date: 2006-11 Impact factor: 1.889
Authors: C K Brown; D L Bartlett; J L Doppman; P Gorden; S K Libutti; D L Fraker; T H Shawker; M C Skarulis; H R Alexander Journal: Surgery Date: 1997-12 Impact factor: 3.982
Authors: M Filippella; M V Davì; G Doveri; E Lillaz; A Ciccarelli; E Massimetti; M Toaiari; M Falconi; A Colao; A Faggiano Journal: J Endocrinol Invest Date: 2010-04-12 Impact factor: 4.256
Authors: Stephanie Mj Fliedner; Chunzhang Yang; Eli Thompson; Mones Abu-Asab; Chang-Mei Hsu; Gary Lampert; Lee Eiden; Arthur S Tischler; Robert Wesley; Zhengping Zhuang; Hendrik Lehnert; Karel Pacak Journal: Am J Cancer Res Date: 2015-03-15 Impact factor: 6.166
Authors: Hilda Wong; Thomas Yau; Pierre Chan; Irene O L Ng; Gavin Chan; Peter Hui; W L Law; C M Lo; Antony J Hedley; Richard J Epstein Journal: Pathol Oncol Res Date: 2009-08-20 Impact factor: 3.201